Shimadzu DryLab - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Shimadzu DryLab


Powerful team for excellent separation and Design Space modeling DryLab & Shimadzu UHPLC

Method registration and validation requires detailed results concerning stability and robustness according to a design space. The well-known and accepted DryLab* software offers unique tools for supporting method development. Based on defined experiments, the design space of the method is modeled in a 3D cube. Each side represents a combination of parameters (mobile phase composition, temperature and pH) – moving inside this cube, the associated separation is modeled and displayed. Areas with good separation are displayed to visualize the design space of this method.

The accuracy of these calculations has been proven by many users. Prediction of retention, using DryLab’s algorithms, matches very well with real results. The design space model adds real value by providing a framework for small method adaptation, which makes it easier to adapt parameters based on new columns, detection or instrumentation as long these changes are executed within the given ‘space’.

Shimadzu’s UHPLC system is controlled via a software interface to LC solution software, methods can be set in PeakMatch and data files are read directly.

(*DryLab is a product of the Molnár Institute of applied chromatography Berlin)

For further details please visit www.shimadzu.eu

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
30%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
30%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans

Click here